Rajasthan simplifies procedure for treatment and reimbursement
On 27th May, 2021 the Govt. of Rajasthan issued the following measures for the simplification of procedure for treatment and reimbursement related to COVID-19 infections under Rajasthan Civil services (Medical Attendance) Rules, 2013-
The State Government employees or their dependent family members, who are suffering from symptoms suggestive of COVID-19 illness can take facility of testing or RT-PCR / RAT from any approved / PPP hospital within the State and shall pay for the test as per the rates notified by Medical and Health Department. Government servant can claim reimbursement as per rule 7 of RCS (MA) Rules, 2013 from their respective offices subsequently.
Tele-medicine services with Government specialists through the e-sanjeevani portal. The details and procedures regarding Tele medicine services through www.esanjeevaniopd.in can be seen on http://www.raiswasthva.nic.in. The e-prescription generated through e-sanjeevaniopd portal can be used for purchase of medicines as prescribed under RCS (MA) Rules, 2013.
In case, State Government employees or their family members need further investigations for inflammatory markers like CRP, D-Dimer, IL-6, or any other routine or specialized investigation like HRCT etc., then they have to pay for the tests as per the rates notified by Medical and Health Department. All the Approved and PPP Hospitals are bound to charge rates as prescribed by Medical and Health Department. Government servant can claim reimbursement as per rule 7 of RCS (MA) Rules, 2013 from their respective offices subsequently.
Medicines like Remdesivir, Tocilizumab are reserved only for patients who are hospitalized and therefore, no reimbursement shall be permitted for such medicines which are not to be administered to patients in Home isolation.
Food supplements and such other inadmissible items under RCS (MA) Rules, 2013 shall however, not be considered for reimbursement
